OneMain Holdings' CFO Jenny Osterhout reported that their nonprime customers, typically with a 630 FICO score and stable jobs, are managing their finances well despite inflation and higher gas prices. About half of their customers have been employed for over five years, 40% are homeowners, and the average income is around $80,000. Payment behaviors remain strong, indicating these consumers are adjusting their budgets effectively to cope with economic pressures. This suggests resilience in a segment often viewed as vulnerable during inflationary periods.
OneMain Holdings, Inc. is the subject of this report. For readers following the Financials sector, here is Pluang's market snapshot as of Sep 16, 2026 01:02 WIB: out of 74 priced US Financials stocks tradable on Pluang, 13 rose and 59 fell. Notable movers include UPST at USD 25.36 with a -2.84% change, BCS at USD 25.28 with a -2.24% change, and ALLY at USD 41.06 with a -2.10% change.
Uber Technologies reported a 25% year-over-year increase in gross bookings to $53.7 billion in Q1 2026, driven by growth in ride-hailing, delivery, grocery, retail, and membership services. CEO Dara Khosrowshahi's recent purchase of 141,000 shares wo...
Waystar Holding Corp, a healthcare software company valued at around $5.1 billion, saw its stock rise 8.6% to $27.05 following reports that it is evaluating strategic options, including a potential sale. Barclays set a new price target of $30, sugges...
MasterCraft Boat Holdings reported fiscal Q4 2026 adjusted earnings of $0.67 per share and revenue of $129.94 million, surpassing estimates. Revenue growth was driven by its Performance and Wake business and the Marine Products acquisition, which add...
Redwood Trust's CFO, Carillo Brooke, increased her stake by purchasing 26,065 shares, showing confidence despite a major shareholder urging the board to consider selling the company. The stock trades at a 33% discount to its GAAP book value due to ri...
BioMarin Pharmaceutical received a price target upgrade to $97 from BMO Capital, reflecting about 50% upside from current levels. This follows positive Phase 3 trial results for VOXZOGO®, a treatment for hypochondroplasia, showing significant growth ...
